Related references
Note: Only part of the references are listed.Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B
Terry Cheuk-Fung Yip et al.
JOURNAL OF HEPATOLOGY (2020)
Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2020)
Clinical utility of hepatocellular carcinoma risk scores in chronic hepatitis B
Thodoris Voulgaris et al.
LIVER INTERNATIONAL (2020)
On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular Carcinoma
Hung-Wei Wang et al.
CANCERS (2020)
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
Rong Fan et al.
JOURNAL OF HEPATOLOGY (2020)
Association of metabolic risk factors with risk of cancer and all-cause mortality in patients with chronic hepatitis B virus infection: a Korean nationwide cohort study
Yun Bin Lee et al.
JOURNAL OF HEPATOLOGY (2020)
Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis
Hong-Lian Gui et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2020)
Epidemiology and Management of Hepatocellular Carcinoma
Laura Kulik et al.
GASTROENTEROLOGY (2019)
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
Kristina Tzartzeva et al.
GASTROENTEROLOGY (2018)
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Naoto Fujiwara et al.
JOURNAL OF HEPATOLOGY (2018)
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B
Yao-Chun Hsu et al.
JOURNAL OF HEPATOLOGY (2018)
Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk
Peipei Ren et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy
Ji Hyun Kim et al.
JOURNAL OF HEPATOLOGY (2018)
An Assessment of Benefits and Harms of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis
Omair Atiq et al.
HEPATOLOGY (2017)
Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome
Allison J. Kasmari et al.
AMERICAN JOURNAL OF MEDICINE (2017)
Real-world risk score for hepatocellular carcinoma (RWS-HCC): a clinically practical risk predictor for HCC in chronic hepatitis B
Zhongxian Poh et al.
GUT (2016)
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2016)
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2015)
Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2015)
Prediction of Development of Liver-Related Events by Transient Elastography in Hepatitis B Patients With Complete Virological Response on Antiviral Therapy
Hye Won Lee et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Prediabetes and the risk of cancer: a meta-analysis
Yi Huang et al.
DIABETOLOGIA (2014)
Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B-A Nationwide Cohort Study
Chun-Ying Wu et al.
GASTROENTEROLOGY (2014)
Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B
Yao-Chun Hsu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B
Grace Lai-Hung Wong et al.
JOURNAL OF HEPATOLOGY (2014)
Increased Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients With Newly Diagnosed Diabetes: A Nationwide Cohort Study
Yi-Wen Huang et al.
CLINICAL INFECTIOUS DISEASES (2013)
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
Hsiao-Ping Chen et al.
GUT (2013)
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies
Chenggang Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Hwai-I Yang et al.
LANCET ONCOLOGY (2011)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2010)
Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
Vincent Wai-Sun Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2010)
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis
Cristina Ripoll et al.
JOURNAL OF HEPATOLOGY (2009)
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
Man-Fung Yuen et al.
JOURNAL OF HEPATOLOGY (2009)
Share Paper
